4 studies on Neuroprotection mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**The timing of Epithalon administration matters critically** — administering the peptide only postnatally yields benefit, but beginning treatment in the maternal generation before conception and continuing through pr…
**Semax's superiority over PGP under ischemia** suggests the N-terminal portion of the molecule — beyond the shared PGP tripeptide — contributes critical neuroprotective properties that cannot be reduced to its C-end …
**Selank and MIF may accelerate functional neurological recovery after ICH independently of hematoma clearance**, pointing to a neuroprotective mechanism — possibly immunomodulatory — rather than a purely mechanical o…
These compelling results indicate that Semax possesses significant neuroprotective and cognitive-enhancing properties in a relevant animal model of ischemic stroke. The observed reductions in infarct volume and improv…